Brevan Howard Capital Management’s Boston Scientific BSX Stock Holding History

Brevan Howard Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.8M	Sell	171,568 -29,188	-15%	-$2.33M	0.1%	122
2025 Q4	$19.2M	Buy	200,756 +126,912	+172%	+$12.4M	0.21%	72
2025 Q3	$7.21M	Sell	73,844 -4,055	-5%	-$420K	0.03%	170
2025 Q2	$8.37M	Sell	77,899 -10,220	-12%	-$1.03M	0.05%	227
2025 Q1	$8.89M	Sell	88,119 -9,221	-9%	-$929K	0.09%	68
2024 Q4	$8.69M	Buy	97,340 +64,489	+196%	+$5.68M	0.06%	80
2024 Q3	$2.75M	Buy	32,851 +19,331	+143%	+$1.52M	0.02%	211
2024 Q2	$1.04M	Buy	+13,520	New	+$990K	0.01%	360

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brevan Howard Capital Management's BSX Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Boston Scientific (BSX) stake by 15% in Q1 2026, selling an estimated $2.33M and leaving 171,568 shares worth $10.8M. The position accounts for 0.1% of the portfolio, ranked #122.

Brevan Howard Capital Management first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $19.2M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Brevan Howard Capital Management held 171,568 shares of Boston Scientific worth $10.8M as of Q1 2026.
Brevan Howard Capital Management sold 29,188 Boston Scientific shares in Q1 2026, an estimated $2.33M.
Boston Scientific made up 0.1% of Brevan Howard Capital Management's portfolio in Q1 2026, its #122 holding.
Brevan Howard Capital Management first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
Brevan Howard Capital Management's Boston Scientific position peaked at $19.2M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.